Report copyright - Reversible Hepatic Cytolysis Secondary to Sunitinib in ... · treated for metastatic renal carcinoma who presented a hepatic cytolysis after introduction the sunitinib: 50mg/day,
Please pass captcha verification before submit form
Please pass captcha verification before submit form